Avience Biomedicals (NSE:AVIENCE) Insider Ownership: 0.00 % (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
18 GF Score
Price ₹250.90
! 3 Warning Signs
View Full Analysis

What is Avience Biomedicals Insider Ownership?

Avience Biomedicals NSE:AVIENCE +1.17% 18 Insider Ownership is 0.00 % as of Aug. 13, 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Avience Biomedicals's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Avience Biomedicals's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Avience Biomedicals's Float Percentage Of Total Shares Outstanding is 0.00%.

Avience Biomedicals Insider Ownership Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Insider Ownership Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Insider Ownership
0.00 0.00 0.00

Avience Biomedicals Semi-Annual Data
Mar23 Mar24 Mar25
Insider Ownership 0.00 0.00 0.00
NSE:AVIENCE
18GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
Avience Biomedicals (NSE:AVIENCE) has a Insider Ownership of 0.00 % as of Aug. 13, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' Insider Ownership too high?
Avience Biomedicals' current Insider Ownership is 0.00 %. Overall, Avience Biomedicals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Insider Ownership compare to ABT and SYK?
Avience Biomedicals' Insider Ownership of 0.00 % can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Devices & Instruments company?
A good Insider Ownership depends on the Medical Devices & Instruments industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Insider Ownership of 0.00 %. The current Insider Ownership is 0.00 %. Avience Biomedicals' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Insider Ownership is 0.00 % as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
18GF Score

Get the complete analysis for NSE:AVIENCE

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹250.90
Price